Mankor, J. M., Disselhorst, M. J., Poncin, M., Baas, P., Aerts, J. G., & Vroman, H. (2020). Efficacy of nivolumab and ipilimumab in patients with malignant pleural mesothelioma is related to a subtype of effector memory cytotoxic T cells: Translational evidence from two clinical trials. EBioMedicine.

Mankor, Joanne M., Maria J. Disselhorst, Myrthe Poncin, Paul Baas, Joachim G.J.V Aerts, and Heleen Vroman. "Efficacy of Nivolumab and Ipilimumab in Patients With Malignant Pleural Mesothelioma Is Related to a Subtype of Effector Memory Cytotoxic T Cells: Translational Evidence From Two Clinical Trials." EBioMedicine 2020.

Mankor, Joanne M., et al. "Efficacy of Nivolumab and Ipilimumab in Patients With Malignant Pleural Mesothelioma Is Related to a Subtype of Effector Memory Cytotoxic T Cells: Translational Evidence From Two Clinical Trials." EBioMedicine 2020.